These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7675372)

  • 21. Body fat patterning in polycystic ovary syndrome women as a predictor of the response to clomiphene.
    Douchi T; Oki T; Yamasaki H; Nakae M; Imabayashi A; Nagata Y
    Acta Obstet Gynecol Scand; 2004 Sep; 83(9):838-41. PubMed ID: 15315595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adrenal androgen excess and body mass index in polycystic ovary syndrome.
    Moran C; Arriaga M; Arechavaleta-Velasco F; Moran S
    J Clin Endocrinol Metab; 2015 Mar; 100(3):942-50. PubMed ID: 25514100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subcutaneous adipose tissue pattern in lean and obese women with polycystic ovary syndrome.
    Tafeit E; Möller R; Rackl S; Giuliani A; Urdl W; Freytag U; Crailsheim K; Sudi K; Horejsi R
    Exp Biol Med (Maywood); 2003 Jun; 228(6):710-6. PubMed ID: 12773703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma visfatin levels in normal weight women with polycystic ovary syndrome.
    Panidis D; Farmakiotis D; Rousso D; Katsikis I; Delkos D; Piouka A; Gerou S; Diamanti-Kandarakis E
    Eur J Intern Med; 2008 Oct; 19(6):406-12. PubMed ID: 18848173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum leptin levels in women with polycystic ovary syndrome: the role of insulin resistance/hyperinsulinemia.
    Laughlin GA; Morales AJ; Yen SS
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1692-6. PubMed ID: 9177365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Difference in non-weight-bearing effects on bone mineral density between trunk and peripheral fat mass in women with polycystic ovary syndrome.
    Yanazume Y; Kawamura Y; Kuwahata A; Yonehara Y; Matsuo T; Iwamoto I; Douchi T
    J Obstet Gynaecol Res; 2010 Apr; 36(2):352-6. PubMed ID: 20492387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperandrogenism Accompanies Increased Intra-Abdominal Fat Storage in Normal Weight Polycystic Ovary Syndrome Women.
    Dumesic DA; Akopians AL; Madrigal VK; Ramirez E; Margolis DJ; Sarma MK; Thomas AM; Grogan TR; Haykal R; Schooler TA; Okeya BL; Abbott DH; Chazenbalk GD
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4178-4188. PubMed ID: 27571186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Body composition, fat distribution and metabolic characteristics in lean and obese women with polycystic ovary syndrome.
    Faloia E; Canibus P; Gatti C; Frezza F; Santangelo M; Garrapa GG; Boscaro M
    J Endocrinol Invest; 2004 May; 27(5):424-9. PubMed ID: 15279073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance.
    Mannerås-Holm L; Leonhardt H; Kullberg J; Jennische E; Odén A; Holm G; Hellström M; Lönn L; Olivecrona G; Stener-Victorin E; Lönn M
    J Clin Endocrinol Metab; 2011 Feb; 96(2):E304-11. PubMed ID: 21084397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.
    Feng JG; Guo Y; Ma LA; Xing J; Sun RF; Zhu W
    J Cosmet Dermatol; 2018 Jun; 17(3):511-517. PubMed ID: 28940857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ghrelin levels are suppressed and show a blunted response to oral glucose in women with polycystic ovary syndrome.
    Barber TM; Casanueva FF; Karpe F; Lage M; Franks S; McCarthy MI; Wass JA
    Eur J Endocrinol; 2008 Apr; 158(4):511-6. PubMed ID: 18362298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum adiponectin in women with polycystic ovarian syndrome and its relation to clinical, metabolic and endocrine parameters.
    Sieminska L; Marek B; Kos-Kudla B; Niedziolka D; Kajdaniuk D; Nowak M; Glogowska-Szelag J
    J Endocrinol Invest; 2004 Jun; 27(6):528-34. PubMed ID: 15717649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.
    Morrison SA; Goss AM; Azziz R; Raju DA; Gower BA
    Hum Reprod; 2017 Jan; 32(1):185-192. PubMed ID: 27827322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
    Yilmaz SA; Kerimoglu OS; Pekin AT; Incesu F; Dogan NU; Celik C; Unlu A
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
    Ardawi MS; Rouzi AA
    Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subcutaneous and omental fat expression of adiponectin and leptin in women with polycystic ovary syndrome.
    Carmina E; Chu MC; Moran C; Tortoriello D; Vardhana P; Tena G; Preciado R; Lobo R
    Fertil Steril; 2008 Mar; 89(3):642-8. PubMed ID: 17562334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of hand functions in women with polycystic ovary syndrome.
    Soyupek F; Guney M; Eris S; Cerci S; Yildiz S; Mungan T
    Gynecol Endocrinol; 2008 Oct; 24(10):571-5. PubMed ID: 19012100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reproductive hormone levels and anthropometry in postmenopausal women with polycystic ovary syndrome (PCOS): a 21-year follow-up study of women diagnosed with PCOS around 50 years ago and their age-matched controls.
    Schmidt J; Brännström M; Landin-Wilhelmsen K; Dahlgren E
    J Clin Endocrinol Metab; 2011 Jul; 96(7):2178-85. PubMed ID: 21508129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stability of adrenocortical steroidogenesis over time in healthy women and women with polycystic ovary syndrome.
    Yildiz BO; Woods KS; Stanczyk F; Bartolucci A; Azziz R
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5558-62. PubMed ID: 15531511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dehydroepiandrosterone sulfate/free androgen index ratio predicts a favorable metabolic profile in patients with polycystic ovary syndrome.
    Nadir A; Temizkan S; Ozderya A; Temizkan O; Orbay E; Aydin K
    Gynecol Endocrinol; 2019 Feb; 35(2):128-132. PubMed ID: 30324855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.